Company Search:
Advanced Search
Sponsored Links
Hvivo PLC Company Snapshot
Hvivo PLC operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hvivo PLC with three other pharmaceutical manufacturers in Europe: Hofseth Biocare ASA of Norway (2017 sales of 118.48 million Norwegian Kroner [US$13.76 million] ), Farmsintez PAO of Russia (723.50 million Russian Rubles [US$10.92 million] ), and Venture Life Group plc (£16.05 million [US$20.74 million] ).

Sales Analysis. During the year ended December of 2017, sales at Hvivo PLC were £10.88 million (US$14.05 million). This is a sharp decrease of 45.2% versus 2016, when the company's sales were £19.85 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hvivo PLC
  Stock Performance Chart for Hvivo PLC
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 27.00p
(Figures in Pounds Sterling)
1 Week -6.9%   13 Weeks -6.9%  
4 Weeks -8.5%   52 Weeks -49.1%  
Hvivo PLC Key Data:
  Ticker: HVO Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 10,878,000
(Year Ending Jan 2018).
Employees: 168
  Currency: Pounds Sterling Market Cap: 21,118,357
  Fiscal Yr Ends: December Shares Outstanding: 78,216,137
  Share Type: Ordinary Closely Held Shares: 4,661,028
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.